Astragaloside IV Ameliorates Airway Inflammation in an Established Murine Model of Asthma by Inhibiting the mTORC1 Signaling Pathway

Astragaloside IV (AS-IV), a main active constituent of Astragalus membranaceus, has been confirmed to have antiasthmatic effects. However, it remained unclear whether the beneficial effects of AS-IV on asthma were attributed to the mTOR inhibition; this issue was the focus of the present work. BALB/...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Hualiang, Wang, Limin, Li, Bei, Cai, Cui, Ye, Jian, Xia, Junbo, Ma, Shenglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676443/
https://www.ncbi.nlm.nih.gov/pubmed/29234390
http://dx.doi.org/10.1155/2017/4037086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5676443/
https://www.ncbi.nlm.nih.gov/pubmed/29234390
http://dx.doi.org/10.1155/2017/4037086

Ejemplares similares